Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 72(3): 1040-9, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10037475

ABSTRACT

An in vitro model of Gaucher's disease in murine neuroblastoma x rat glioma NG108-15 cells was used to investigate the physiological effects of two specific inhibitors of glucosylceramide synthase, d,l-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (d,l-PDMP) and N-butyldeoxynojirimycin (NB-DNJ), which have been suggested as agents for treatment of glycolipid storage disorders. Incubation of NG108-15 cells with conduritol-B-epoxide, a covalent inhibitor of glucosylceramidase, raised the intracellular concentration of glucosylceramide (GC) by more than fourfold, indicating a glycolipid composition equivalent to that of Gaucher's cells. The level of GC was decreased, and the cells were depleted of gangliosides by postincubation with d,l-PDMP or NB-DNJ. Treatment with d,l-PDMP, but not with NB-DNJ, resulted in a dose-dependent reduction of the growth rate and eventually caused cell death in NG108-15 cells on reaching confluency. An in situ detection assay using terminal nucleotidyltransferase indicated that cell degeneration was accompanied by apoptosis. Lipid analysis by high-performance TLC revealed that on incubation with d,l-PDMP, but not with NB-DNJ, the concentration of endogenous ceramide was elevated by threefold. Ceramide elevation and apoptosis were also observed when NG108-15 cells were incubated with daunorubicin, which was previously reported to induce programmed cell death by stimulation of ceramide synthesis. Structural characterization by HPLC and subsequent laser desorption mass spectrometry revealed that the endogenous ceramide contained fatty acids with chain lengths ranging from C14:0 to C24:0. The results indicate that elevation of levels of these ceramide species by incubation with d,l-PDMP or daunorubicin induces programmed cell death in NG108-15 cells. Because ceramide accumulation and cell death were not observed on incubation with NB-DNJ, its use is suggested to be less toxic than that of d,l-PDMP for treatment of Gaucher's disease and other sphingolipid storage disorders.


Subject(s)
Brain Neoplasms/pathology , Ceramides/physiology , Gaucher Disease/pathology , Glycolipids/antagonists & inhibitors , Neuroblastoma/pathology , 1-Deoxynojirimycin/analogs & derivatives , 1-Deoxynojirimycin/pharmacology , Animals , Apoptosis/drug effects , Brain Neoplasms/metabolism , Cell Death/drug effects , Cell Division/drug effects , Ceramides/metabolism , Ceramides/toxicity , Enzyme Inhibitors/pharmacology , Gaucher Disease/metabolism , Glucosylceramides/antagonists & inhibitors , Glucosyltransferases/antagonists & inhibitors , Glycolipids/biosynthesis , Mice , Morpholines/pharmacology , Neuroblastoma/metabolism , Rats , Tumor Cells, Cultured
2.
J Neurochem ; 71(3): 972-9, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9721722

ABSTRACT

Cell differentiation is frequently accompanied by alterations in the composition of gangliosides in the plasma membrane resulting from a regulation of the enzyme activities involved. The regulation of CMP-NeuAc:GM1 alpha2-3-sialyltransferase (ST-IV) and UDP-GalNAc:GM3 N-acetylgalactosaminyltransferase (Gal-NAc-T) by the degree of enzyme phosphorylation was analyzed by determination of the enzyme activity on incubation of NG108-15 cells with various protein phosphatase inhibitors (okadaic acid and orthovanadate) or protein kinase activators (phorbol ester and forskolin). Incubation with okadaic acid, but not with orthovanadate, inhibited the ST-IV activity to 45% of that of control cells with t(1/2) = 60 min for the inactivation reaction. This indicates a rapid hyperphosphorylation of ST-IV due to the inhibition of a serine/threonine-specific phosphatase. A similar rate of inactivation was found on stimulation of protein kinase C with phorbol ester. In contrast to ST-IV, the activity of GalNAc-T was increased on stimulation of intracellular phosphorylation systems. The fastest activation of GalNAc-T was achieved with forskolin, yielding up to 160% of the initial activity within 30 min of effector incubation. Up-regulation of GalNAc-T in conjunction with down-regulation of ST-IV by stimulation of phosphorylation is suggested to serve as a physiological mechanism to increase the concentration of GM1, which was found to be elevated in correlation with the cell density. This assumption was corroborated by metabolic labeling studies with radioactive ganglioside precursors indicating an enhancement of the relative amount of a-series gangliosides subsequent to GM3 on phosphorylation stimulation. In particular, the biosynthesis of GM1 was specifically elevated within 2 h of incubation with forskolin. We conclude from the overall data that the ganglioside composition during the cell differentiation of NG108-15 cells can be specifically regulated by both protein kinase A- and protein kinase C-related phosphorylation systems.


Subject(s)
Gangliosides/metabolism , Animals , Cell Count , Glycosyltransferases/metabolism , Mice , N-Acetylgalactosaminyltransferases/metabolism , Phosphorylation , Rats , Sialyltransferases/metabolism , Tumor Cells, Cultured , Polypeptide N-acetylgalactosaminyltransferase
4.
J Neurochem ; 68(5): 2070-8, 1997 May.
Article in English | MEDLINE | ID: mdl-9109534

ABSTRACT

A previous study has demonstrated an unusual gangliosidosis in emu that is characterized by the accumulation of gangliosides in the brain tissues with GM3 and GM1 predominating. To provide insight into this unique disorder of emu gangliosidosis, the current study focused on analysis of neutral glycosphingolipids and gangliosides from brain and liver tissues of affected birds and healthy controls. We found not only that the total lipid-bound sialic acid content was increased three- and fourfold in the affected brain and liver, respectively, but also that the ganglioside pattern was rather complex as compared with the control. The absolute ganglioside sialic acid content was significantly increased in the diseased tissues, with the highest elevation levels of GM3 (14-fold) and GM1 (ninefold) in the affected brain. Relative increases in content of these monosialogangliosides were also significant. GM2 was only detected in the affected brain, but not in normal controls. The neutral glycosphingolipid fraction showed accumulation of many oligosylceramides, with six- and 5.5-fold increases in lactosylceramide levels for brain and liver, respectively. The level of myelin-associated galactosylceramide (GalCer) in the brain was decreased to only 41% of that in the healthy control, whereas no difference was found in liver tissues from both groups. Besides GalCer, the brain content of sulfatide (cerebroside-sulfate esters), another myelin-associated glycolipid, decreased to only 16% of the control. The loss of myelin-associated GalCer and sulfatide strongly suggests demyelination in the affected emu brain. Our overall data are consistent with the presence of a unique form of sphingolipidosis in the affected emus, perhaps with secondary demyelination, and suggest a metabolic disorder related to total sphingolipid activator deficiency.


Subject(s)
Antigens, CD , Bird Diseases/metabolism , Gangliosidoses/veterinary , Animals , Birds , Brain/metabolism , Galactose/metabolism , Galactosylceramides/metabolism , Gangliosides/metabolism , Gangliosidoses/metabolism , Glucose/metabolism , Glycolipids/metabolism , Lactosylceramides/metabolism , Lipid Metabolism , Liver/metabolism , N-Acetylneuraminic Acid/metabolism , Nerve Tissue Proteins/metabolism , Sulfoglycosphingolipids/metabolism
5.
Avian Dis ; 41(4): 838-49, 1997.
Article in English | MEDLINE | ID: mdl-9454917

ABSTRACT

The progeny of two emu breeder pairs, which had a history of producing offspring with gangliosidosis, were monitored for 15 mo. DNA fingerprinting revealed that individuals in each breeder pair were not related to each other. One breeder pair had 13 progeny that reached or exceeded the age of 1 mo, and six of these progeny developed gangliosidosis. The mean age at which these affected emus were euthanatized, with distinct neurologic disease, or died was 5.7 mo. The second emu pair had 13 progeny, seven of which developed gangliosidosis, with a mean age of euthanasia/death of 4.6 mo. Affected emus died or were euthanatized from 2 to 8 mo of age. The primary clinical sign in the affected emus was mild to severe ataxia. Severe hemorrhage into the body cavity or the muscles of the thigh was noted in 8 of 13 of the affected emus. Brain ganglioside levels were evaluated in six of the affected emus and six controls. Significant increases (P < 0.05) in gangliosides GM1 and GM3 were noted, with 2.3- and 4.9-fold increases in these two gangliosides, respectively, in affected emus. Furthermore, the diseased emu brains contained ganglioside GM2, whereas this monosialoganglioside was undetectable in the brains of normal controls. Total mean brain ganglioside sialic acid in affected emus was increased 3.3-fold in comparison with controls. Serum chemistries revealed elevated cholesterol and decreased uric acid levels in affected emus. Gangliosidosis in emus is an inherited disease process that, in the current study, caused 50% mortality in the progeny of two emu breeder pairs. The elimination of this lethal gene from emu breeder stock is essential for the long-term economic viability of the United States emu industry.


Subject(s)
Gangliosidoses/veterinary , Poultry Diseases/blood , Poultry Diseases/genetics , Animals , Birds , Blood Coagulation/physiology , Brain/pathology , Brain/ultrastructure , Brain Chemistry , Breeding , Cholesterol/blood , DNA/analysis , DNA/chemistry , DNA/genetics , DNA Fingerprinting/veterinary , Female , Gangliosides/analysis , Gangliosidoses/blood , Gangliosidoses/genetics , Genes, Lethal/genetics , Kidney Tubules/pathology , Liver/pathology , Liver/ultrastructure , Macrophages/pathology , Male , Microscopy, Electron/methods , Microscopy, Electron/veterinary , Muscle, Skeletal/pathology , Polymorphism, Restriction Fragment Length , Poultry Diseases/pathology , Uric Acid/blood
6.
J Neurochem ; 64(1): 385-93, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7798936

ABSTRACT

To characterize the sialyltransferase-IV activity in brain tissues, the activities of GM1b-, GD1a-, GT1b-, and GQ1c-synthases in adult cichlid fish and rat brains were examined using GA1, GM1, GD1b, or a cod brain ganglioside mixture as the substrate. The GD1a-synthase activity in the total membrane fraction from cichlid fish brain required divalent cations such as Mg2+ or Mn2+ and Triton CF-54 for its full activity. The Vmax value was 1,340 pmol/mg of protein/h at an optimal pH of 6.5, whereas the apparent Km values for CMP-sialic acid and GM1 were 172 and 78 microM, respectively. Cichlid fish and rat brains also contained GM1b-, GT1b-, and GQ1c-synthase activities. The ratio of GM1b-, GD1a-, and GT1b-synthase activities in fish brain was 1.00:0.89:1.13, respectively, and in rat brain 1.00:0.60:0.63. Incubation of fish brain membranes with a cod brain ganglioside mixture, which contains GT1c, and [3H]CMP-sialic acid produced radiolabeled GQ1c. It is interesting that the adult rat brain also contains an appreciable level of GQ1c-synthase activity despite its very low concentrations of c-series gangliosides. The GD1a- or GQ1c-synthase activity in fish and rat brain was inhibited specifically by coincubation with the glycolipids that serve as the substrates for other sialyltransferase-IV reactions. Thus, the GD1a-synthase activity was inhibited by GA1 and GD1b, but not by LacCer, GM3, or GD3. In a similar manner, the synthesis of GQ1c was suppressed by GA1, GM1, and GD1b, but not by LacCer, GM3, or GD3.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Brain/metabolism , Gangliosides/metabolism , Sialyltransferases/analysis , Sialyltransferases/physiology , Animals , Brain Chemistry , Cholic Acids/pharmacology , Female , Gangliosides/analysis , Hydrogen-Ion Concentration , Magnesium/pharmacology , Manganese/pharmacology , Octoxynol/pharmacology , Perches , Rats , Rats, Sprague-Dawley , Sialyltransferases/metabolism
7.
J Neurochem ; 62(5): 1965-73, 1994 May.
Article in English | MEDLINE | ID: mdl-8158143

ABSTRACT

To investigate the role of sialyltransferases in the metabolism of brain gangliosides, we examined activities of five different sialyltransferases (GM3-, GD3-, GT3-, GD1a-, and GT1a-synthase) using total membrane preparations from cichlid fish and Sprague-Dawley rat brains, and analyzed the relationship between the enzyme activities and the ganglioside compositions. The patterns of sialyltransferase activities in fish and rat brains differed from each other. In fish brain, the GM3-synthase activity was lower than GD3-synthase activity, whereas the opposite relationship was observed in rat brain. The GT3-synthase reaction with fish brain membranes produced radiolabeled GM3, GD3, and a ganglioside that was identified as GT3 based on mobility on TLC using two different solvent systems. No GT3-synthase activity was detected in rat brain. The GD1a- and GT1a-synthase activities in fish brain were higher than those in rat brain. Although GT1a was a single radiolabeled ganglioside in fish GT1a-synthase reaction, this ganglioside could not be detected in rat brain. The ratios of GM3-, GD3-, GT3-, GD1a-, and GT1a-synthase activities in fish and rat brain were 23:31:4:28:14 and 61:21:0:18:0, respectively. Ganglioside analysis showed that fish brain was enriched with c-series gangliosides including GT3 and polysialo-species, whereas a- and b-series gangliosides were major components in rat brain. These results suggest that the species-specific expression of gangliosides in brain tissues may be regulated, at least in part, at the level of sialyltransferase activities.


Subject(s)
Brain/enzymology , Gangliosides/biosynthesis , Sialyltransferases/metabolism , Animals , Carbohydrate Sequence , Cell Membrane/enzymology , Female , Gangliosides/chemistry , Gangliosides/isolation & purification , Molecular Sequence Data , Perches , Rats , Rats, Sprague-Dawley , Species Specificity
8.
Adv Space Res ; 14(8): 309-12, 1994.
Article in English | MEDLINE | ID: mdl-11537932

ABSTRACT

Quantitative data are presented on the influences of hyper-gravity (3 +/- 1g) and of simulated weightlessness (approximately 0g) during early ontogeny of cichlid fish (Oreochromis mossambicus) and clawed toad (Xenopus laevis, Daudin) demonstrating changes in the swimming behaviour and the brain energy and plasma membrane metabolism. After return to 1g conditions, hyper-g reared fish and toads express the well known "loop-swimming" behaviour. By means of a computer based video analyzing system different types of swimming movements and velocities were quantitatively determined. Analyses of the brain energy and plasma-membrane metabolism of hyper-g fish larvae demonstrated an increase in energy availability (glucose 6Pi dehydrogenase, G-6P-DH), a decrease of cellular energy transformation (creatine kinase activity, CK) but no changes in energy consumptive processes (e.g. ATPases) and cytochrome oxidase activity (Cyt.-Ox). In contrast hypo-g fish larvae showed a slight increase in brain CK activity. In addition, unlike 1g controls, hyper-g fish larvae showed pronounced variations in the composition (=polarity) of sialoglycosphingolipids (=gangliosides), typical constituents of the nerve cell membranes, and a slight increase in the activity of sialidase, the enzyme responsible for ganglioside degradation.


Subject(s)
Brain/physiology , Gravity, Altered , Swimming/physiology , Tilapia/physiology , Xenopus laevis/physiology , Animals , Brain/embryology , Brain/metabolism , Cell Membrane/metabolism , Centrifugation , Creatine Kinase/metabolism , Creatine Kinase/physiology , Energy Metabolism , Glycosphingolipids/metabolism , Gravitation , Hypergravity , Image Processing, Computer-Assisted , Larva/physiology , Rotation , Tilapia/embryology , Tilapia/metabolism , Weightlessness Simulation , Xenopus laevis/embryology , Xenopus laevis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...